|
|
News & Events
News
|
06-May-2010
This symposium aimed to contribute to fostering the safe and efficient development of this new field by identifying issues and areas for future study.
|
|
11-Mar-2010
The main objective of the workshop was to develop a short data intensive report, the OECD Outlook on Industrial Biotechnology. This OECD Outlook is intended to provide data and information on a number of Industrial Biotechnology-related trends and issues. It is expected that the themes addressed during the workshop will also provide the basis for creation of datasets and indicators to improve evidence-based policy making.
|
|
18-Nov-2009
This new book reviews the use of pharmacogenetics across all stages of the health innovation cycle from research through to uptake by doctors and patients. It focuses on how to optimise use of pharmacogenetics to deliver effective innovations for public health, and design policies that enhance their economic and social benefits.
|
|
12-Nov-2009
The recently adopted OECD Recommendation provides guidance on the establishment, management, governance, operation, access, use and discontinuation of HBGRDs. It has been developed to aid policymakers and practitioners who are establishing new HBGRDs, although many of the principles and best practices can also be usefully applied to HBGRDs already in existence.
|
|
20-Mar-2009
This document focuses on efforts in the United States to develop metrics to support sound decision choices by industry and consumers in the selection and use of biobased products. Public policy initiatives have been important in spurring the movement toward increased use of biobased products in the effort to lighten the US environmental footprint and enhance its energy security. This has included developing metrics based on sound science that also provide useful information to inform consumer selections of biobased products.
|
|
24-Oct-2008
The links between innovation, productivity, health and wealth are recognised by many countries and the need to encourage innovation is also apparent. Investing in and encouraging innovation is a priority for many jurisdictions as is the affordability, quality and sustainability of healthcare systems.
|
Top of page
|
|
